MU
34
-2
SPG
48
-2
WU
24
4
NRG
44
-3
EXR
51
-2
NUE
53
2
ADSK
61
2
VRSN
53
3
HST
62
23
BIIB
37
2
CA
40
8
NEE
47
-3
CMA
56
6
MNST
70
14
GOOG
59
-4
DHR
57
-9
EFX
77
2
LNC
58
3
HON
45
-7
ROP
59
5
MU
34
-2
SPG
48
-2
WU
24
4
NRG
44
-3
EXR
51
-2
NUE
53
2
ADSK
61
2
VRSN
53
3
HST
62
23
BIIB
37
2
CA
40
8
NEE
47
-3
CMA
56
6
MNST
70
14
GOOG
59
-4
DHR
57
-9
EFX
77
2
LNC
58
3
HON
45
-7
ROP
59
5
Financhill
Back

Keros Therapeutics Stock Predictions

$1,300 into $45,000 in just 4 MONTHS?!

See here to see the full details.
Buy
62

KROS
Keros Therapeutics

Last Price:
52.52
Seasonality Move:
16.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street's Worst Nightmare: Small Town Trader's AI Edge

See the AI advantage for everyday Americans.

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 17.1% based on the past 4 years of stock performance.
  • Keros Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $50.29. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 17.1% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Buy
62
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
27.02

Prediction Charts

Market Cap:
1.81B
Price in USD:
50.29
Volume:
212.64K
Beta:
1.14

Technical Analysis

SMA50:
47.86
SMA100:
54.94
SMA200:
48.31
52-Wk Change:
17.04%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 50.29 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-8 42.88 41.68 43.27 41.66
Jul-9 41.77 42.74 42.87 40.93
Jul-10 42.87 42.99 43.09 41.96
Jul-11 44.33 45.97 46.97 43.19
Jul-12 46.86 47.46 47.84 46.50
Jul-15 48.04 51.06 51.13 47.50
Jul-16 52.40 52.17 53.69 51.61
Jul-17 51.12 49.72 52.11 48.73
Jul-18 49.61 48.02 49.94 46.35
Jul-19 48.26 48.38 48.65 46.62
Jul-22 48.77 48.57 49.11 47.25
Jul-23 48.19 50.82 51.29 47.98
Jul-24 50.30 49.57 51.26 48.97
Jul-25 50.05 50.29 51.73 49.55

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.